Pharmaceutical Strategic Initiatives

Pharmaceutical Strategic Initiatives (PSI) was a specialized strategic consulting and medical affairs firm serving the pharmaceutical, biotechnology, and medical device industries. Founded in 1994 and headquartered in Research Triangle Park, North Carolina, the company provided a range of services including clinical research design, regulatory strategy, health outcomes research, and key opinion leader (KOL) development. PSI focused on bridging the gap between clinical development and commercialization for its clients, which included over 28 life science companies. The firm was recognized for its expertise in therapeutic areas such as oncology, cardiovascular, and respiratory health before being acquired in 2012.